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This article describes the synthesis of the new (2Z)-2-(4-methoxybenzylidene)-6-nitro-4H-benzo[1,4]thiazin-3-one, (2Z)-2-(4-
methoxybenzylidene)-4-methyl-6-nitro-4H-benzo[1,4]thiazin-3-one, (2Z)-6-amino-2-(4-methoxybenzylidene)-4H-benzo[1,4]
thiazin-3-one, (2Z)-6-butylamino-2-(4-methoxybenzylidene)-4-methyl-4H-benzo[1,4]-thiazin-3-one and (2E)-N-alkyl-N-(2-
hydroxy-5-nitrophenyl)-3-phenylacrylamides and the spectroscopic data. The arylidenebenzothiazine compounds were prepared 
using the Knoevenagel condensation with substituted benzaldehydes in the presence of sodium methoxide in DMF. The presence 
of a nitro substituent in the 4-position, water and a slightly acid reaction medium in this condensation caused the rupture of the 
benzothiazine ring and subsequent formation of the phenylacrylamide compounds. A crystallographic data was presented for (2E)-
3-(4-bromophenyl)-N-dodecyl-N-(2-hydroxy-5-nitrophenyl) acrylamide.
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INTRODUCTION
1,4-Benzothiazine derivatives exhibit a wide range of phar-
macological properties, including antifungal, immunostimulating, 
anti-aldoso-reductase, anti-rheumatic, anti-allergic, vasorelaxant, 
anti-arrhythmic, anti-hypertensive, neuroprotective and cytotoxic 
activities. These properties indicate that 1,4-benzothiazine is a tem-
plate that may be potentially useful in medicinal chemistry research 
and therapeutic applications.1
Gupta and Ojha2 reviewed the chemical and pharmacological 
properties of phenothiazines and 1,4-benzothiazines. Some of the 
latter showed microbiological and antitumor activities.3,4 The syn-
thesis, spectroscopic properties and microbiological activities of se-
veral 6-alkylacylamino-4-methyl-4H-benzo[1,4]thiazin-3-ones have 
also been reported.5 Moreover, the reactivity of a methylene group 
activated by a carbonyl substituent or a thioxo has been studied by 
Guarda and Silva.6,7 Condensation of 1,4-benzothiazin-3-ones with 
arylaldehydes or Michael addition on cyanoacrylates leads to the 
formation of 2-arylidene-4H-benzo[1,4]thiazin-3-one compounds.8
RESULTS AND DISCUSSION
The present study describes the synthesis of substituted (2E)-N-
alkyl-N-(2-hydroxy-5-nitrophenyl)-3-phenylacrylamides, (4-6), (2Z)-2-
(4-methoxybenzylidene)-6-nitro-4H-benzo[1,4]thiazin-3-one, (7), (2Z)-
2-(4-methoxybenzylidene)-4-methyl-6-nitro-4H-benzo[1,4]thiazin-3-
one (8) and (2Z)-6-amino-2-(4-methoxybenzylidene)-4H-benzo[1,4]
thiazin-3-one (9) or (2Z)-6-butylamino-2-(4-methoxybenzylidene)-4-
methyl-4H-benzo[1,4]thiazin-3-one (12), Figure 1. The intermediary 
6-nitro-4H-benzo[1,4]-oxazin-3-one, which were not isolated, were 
obtained as a result of the Knoevenagel condensation of activated 
4-alkyl-6-nitro-4H-benzo[1,4]thiazin-3-one 2-3 with 4-methoxy or 
4-bromobenzaldehydes in the presence of sodium methoxide in DMF.9 
The (2Z)-2-(4-methoxybenzylidene)-4-methyl-6-nitro-4H-ben-
zo[1,4]thiazin-3-one 8 was first condensed in position 2; subsequently, 
alkylation was carried out at position 4.10 Methylation followed by 
condensation did not yield good results. The reduction of the nitro 
group to a primary amine with tin chloride in concentrated hydrochloric 
acid produced (2Z)-6-amino-2-(4-methoxybenzylidene)-4H-benzo[1,4]
thiazin-3-one 9 or 6-amino-4-methyl-4H-benzo[1,4]thiazin-3-one 10.11
The arylidenebenzothiazines (7,12) described in this work were 
isolated in a single isomeric form. It has been previously demonstrated12 
that the Z isomer is the main derivative that is obtained from the standard 
Knoevenagel condensation of benzaldehydes with benzylidene-4H-
benzo[1,4]thiazin-3-ones in an alkaline medium. The study was carried 
out using coupled NMR 13C-H spectrometry. The value of the coupling 
Figure 1. Benzothiazine and acrylamide derivatives: synthetic pathways
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constant between the ethylene proton and the carbon of the carbonyl 
group in position 3 verifies the existence of the Z isomer. 
The (2E)-N-alkyl-N-(2-hydroxy-5-nitrophenyl)-3-phenylacryla-
mides 4-6 were formed due to the presence of the nitro group in the 
para-position, water and the excess of heat lead in a slightly acid 
reaction medium to the formation of the intermediary 6-nitro-4H-
benzo[1,4]-oxazin-3-one and posterior rupture, figure 2. The chemical 
shifts and coupling constants in the 1H NMR of ethylenic protons 
and the crystallographic data show that the N-alkyl-N-(2-hydroxy-
5-nitro-phenyl)-3-phenylacrylamides (4-6) that formed have the E 
configuration.
The spectroscopic characteristics and IR, 1H NMR and MS spec-
troscopic data of the arylidenebenzothiazines and acrylamides that 
were prepared are given in the experimental section. 
Crystallographic data
The crystal data, collection procedures, structure determination 
methods and refinement results for the (2E)-3-(4-bromo-phenyl)-N-
dodecyl-N-(2-hydroxy-5-nitro-phenyl)acrylamide (5) are summarized 
in Table 1. We used the following programs: for the cell determination 
and data collection,13 data reduction,14 data collection,15 structure 
resolution,16 refinement,17 graphic presentation18 and material to 
publication.19
The structure was solved by direct methods and refined by a full-
matrix least squares calculations. The refinement was conducted until 
all atomic parameter shifts were smaller than their standard deviations. 
All H atoms were located by geometrical considerations. In the final 
difference Fourier map there are no peaks greater than 0.34 Å-3. The 
asymmetrical unit consists of two independent molecules, which are 
not related one to the other by symmetry.
In both independent molecules, no conformational differences are 
observed. Bond lengths and angles agree well, within the experimental 
accuracy, with values found in literature, Figure 2.
CONCLUSION
The study of the reactivity of 1,4-benzothiazine heterocyclic ring 
activated in position 3 by carbonyl substituent leads by Knoevenagel con-
densation with arylaldehydes to the formation of arylidenebenzothiazines 
compounds in the form of a single isomer in good yields. Phenylacryla-
mide derivatives were also obtained by rupture of the benzothiazine ring.
EXPERIMENTAL
Melting points were measured on a Quimis Q340D apparatus with 
an oil bath in capillary tubes. Thin layer chromatography was performed 
on Merck 60F254 silica gel plates with a 0.2 mm thickness. Compounds 
were powdered, mixed with KBr at 1% concentration and pressed into 
pellets before infrared spectra were recorded on a FT-IFS 66 Bruker 
spectrometer; the wavelengths are expressed in cm-1. Nuclear magnetic 
resonance spectra were recorded on a Varian Unity Plus spectrometer 
1H NMR at 300 MHz; the chemical shifts (d) are expressed in parts per 
million (ppm) and the coupling constants (J) in Hertz (Hz). DMSO-d6 
was used as the solvent and SiMe4 as the reference. Electronic impact 
(70 eV) mass spectra were recorded on an HP G1019A, coupled to 
a CPG HP 5890 spectrometer; for compounds (5) and (6) chemistry 
ionization was performed in ammonia and isobutane and recorded 
on a Waters ZQ apparatus. The intensities of the molecular peaks are 
presented relative to the most intense peak M+(%). The synthesis and 
the spectroscopic characteristics of 6-nitro-4H-benzo[1,4]thiazin-3-one 
(1), 4-methyl-6-nitro-4H-benzo[1,4]thiazin-3-one (2), 6-amino-4-
methyl-4H-benzo[1,4]thiazin-3-one (10) and 6-butylamino-4-methyl-
4H-benzo[1,4]thiazin-3-one (11) have been already described.5
4-Dodecyl-6-nitro-4H-benzo[1,4]thiazin-3-one (3)
A suspension of 6-nitro-4H-benzo[1,4]thiazin-3-one (1) 0.5 g (2.38 
mmol) in DMSO/EtOH 50% was treated with potassium hydroxide 0.27 
g (4.8 mmol). The reaction mixture was maintained under strong agita-
tion for 10 min at room temperature. Dodecylbromide (1.18 mL, 4.76 
mmol) was added dropwise while stirring. The reaction mixture was 
then maintained under agitation at 55 °C for 15 h. The crude product 
was extracted with ethyl acetate. After solvent evaporation, the com-
pound was purified using flash chromatography on silica 60 (230-400 
Mesh) using toluene as the eluent. The product appeared as a viscous 
oil that crystallized after a few days in a desiccator. C20H30N2O3S, 0.57 g 
(64%), mp 37-39 °C; TLC silica gel plates type 60F254, Rf (C6H6) 0.58; 
IR (potassium bromide) ν
max 
cm-1: 2916, 2849, 1681, 1524, 1342 cm-1; 
1H NMR (300 MHz, DMSO-d6): d 0.85 (t, 3 H, CH3) J 6.9Hz, 1.21 (s, 
16 H, CH2), 1.51 (m, 2 H, CH2CH3), 3.3 (m, 2 H, bCH2), 3.63 (s, 2 H, 
SCH2), 4.06 (t, 2 H, aCH2) J 7.3 Hz, 7.71 (d, 1 H, H8 benzothiazine) 
Figure 2. Perspective view of one molecule from the asymmetric unit of the 
acrylamide 5 with atom-labeling. Displacement of ellipsoids plotted at the 
30% probability level are shown for the non-H atoms
Table 1. Crystal data and structure refinement
Empirical formula C27H35O4N2Br
Formula weight 531.48
Temperature 120(2) K
Wavelength 0.71070 Å
Crystal system Monoclinic
Space group P21
Unit cell dimensions a = 11.0421(5) Å
b =  7.3059(3) Å b= 91.51(2)°
c = 32.3832(16) Å
Volume 2611.5(2) Å3
Z 4
Density (calculated) 1.352 Mg/m3
Absorption coefficient 1.608 mm-1
F(000) 1112
Crystal size 0.12 x 0.10 x 0.10 mm
Theta range for data collection 1.26 to 25.0°
Index ranges -12 ≤ h ≤ 13, -8 ≤ k ≤ 8, -38 ≤ l ≤ 38
Reflections collected 15287
Independent reflections 8677 [R(int) = 0.0163]
Absorption correction Multiscan
Refinement method Full-matrix least-squares on F2
Data / parameters 5425 / 615
Goodness-of-fit on F2 1.046
Final R indices [I>2s(I)] R1 = 0.061, wR2 = 0.1191
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J 8.4 Hz, 7.89 (dd, 1 H, H7 benzothiazine) J 8.4 and 2.4 Hz, 8.02 (d, 1 
H, H5 benzothiazine) J 2.4 Hz.; MS, m/z(%): 378(M+ 7.86), 331(100), 
332(9.7), 329(21.9), 211(12.7), 209(3), 195(17.2), 181(27.4).
General procedure for (2E)-N-alkyl-N-(2-hydroxy-5-
nitrophenyl)-3-phenylacrylamides compounds (4-6)
A mixture of 6-nitro-4-alkyl-4H-benzo[1,4]thiazin-3-one (0.26 
mmol) and substituted benzaldehyde (0.26 mmol) in 3 mL of DMF 
was treated with sodium methoxide in excess. The solution was 
refluxed at 125 °C for 6 h. After cooling, the isolated precipitate was 
washed with water. The compounds were of acceptable purity and 
were analyzed without further recrystallization.
(2E)-3-(4-Bromophenyl)-N-(2-hydroxy-5-nitrophenyl)-N-
methylacrylamide (4)
C16H13BrN2O4, 0.042 g (43%), mp 150-152 °C; TLC silica gel 
plates type 60F254, Rf (CHCl3: EtOH 99.5:0.5) 0.48; IR (potassium 
bromide) ν
max 
cm-1: 3429, 3079, 1656, 1584, 1511, 1340, 1320, 817; 
1H NMR (300 MHz, DMSO-d6): d 3.19 (s, 3 H, CH3), 6.4 (d, 1 H, 
H2 ethylene) J 15 Hz, 7.13 (d, 2 H, H2”6” phenyl) J 9.6 Hz, 7.4 (d, 
1 H, H3’ phenyl) J 7.5 Hz, 7.49 (d, 2 H, H3”5” phenyl) J 8.4 Hz, 7.5 
(d, 1 H, H3 ethylene) J 15.6 Hz, 8.17 (s, 1 H, H6’ phenyl), 8.18 (d, 
1 H, H4’ phenyl) J 7.2 Hz; MS, m/z(%): 376(M+ 2.52), 209(100), 
210(15.5), 211(88.1), 181(19.6), 102(79.8).
(2E)-3-(4-bromophenyl)- N-dodecyl-N-(2-hydroxy-5-
nitrophenyl)acrylamide (5)
C27H35BrN2O4, 0.062 g (45%), mp 117 °C; TLC silica gel plates 
type 60F254, Rf (C6H6: AcOEt 8:2) 0.62; IR (potassium bromide) νmax 
cm-1: 2924, 2853, 1642, 1599, 1530, 1341, 1305; 1H NMR (300 MHz, 
DMSO-d6): d 0.84 (t, 3 H, CH3) J 7.2 Hz, 1.21 (s, 16 H, CH2), 1.44 
(m, 2 H, CH2CH3), 3.51 (m, 2 H, bCH2), 3.76 (m, 2 H, aCH2), 6.34 
(d, 1 H, H2 ethylene) J 15.6 Hz, 7.09 (d, 1 H, H3’ phenyl) J 9.3 Hz, 
7.38 (d, 2 H, H2”6” phenyl) J 8.7 Hz, 7.48 (d, 1 H, H3 ethylene) J 15 
Hz, 7.51 (d, 2 H, H3”5” phenyl) J 8.4 Hz, 8.06 (d, 1 H, H6’ phenyl) J 
3 Hz, 8.17 (dd, 1 H, H4’ phenyl) J 9.3 and 2.6 Hz; DCI, NH3/isobu-
tane: 531(MH+ 100), 532(M+2 39.39), 533(MH++2 64.49), 397(3.9), 
323(21.4), 209(19), 211(15.3), 167(7.2), 130(5.5).
(2E)- N-dodecyl-N-(2-hydroxy-5-nitrophenyl)-3-(4-
methoxyphenyl)acrylamide (6)
C28H38N2O5, 0.055 g (44%), mp 130-132 °C; TLC silica gel plates 
type 60F254, Rf (C6H6:AcOEt 8:2) 0.67; IR (potassium bromide) νmax 
cm-1: 2926, 2854, 1645, 1604, 1513, 1336, 1250, 828; 1H NMR (300 
MHz, DMSO-d6): d 0.84 (t, 3 H, CH3) J 6.6Hz, 1.22 (s, 16 H, CH2), 
1.42 (m, 2 H, CH2CH3), 3.32 (m, 2 H, bCH2 hidden for the water), 
3.74 (s, 3 H, OCH3), 3.79 (m, 2 H, aCH2), 6.2 (d, 1 H, H2 ethylene) 
J 15.6 Hz, 6.63 (d, 1 H, H3’ phenyl) J 9.9 Hz, 6.88 (d, 2 H, H3”5” 
phenyl) J 9 Hz, 7.31 (d, 2 H, H2”6” phenyl) J 8.7 Hz, 7.4 (d, 1 H, 
H3 ethylene) J 15.6 Hz, 7.86 (d, 1 H, H6’ phenyl) J 3 Hz, 7.96 (dd, 
1 H, H4’ phenyl) J 9.1 and 2.8 Hz; MS, m/z(%) DCI, NH3/isobu-
tane: 483(MH+ 0.95), 409(46.6), 384(22.5), 328(20.5), 295(51.2), 
273(100), 247(29.4), 191(58), 163(68.3).
(2Z)-2-(4-Methoxybenzylidene)-6-nitro-4H-benzo[1,4]thiazin-
3-one (7)
An equimolar mixture of 6-nitro-4H-benzo[1,4]thiazin-3-one (1) 
(250 mg, 1.19 mmol) and 4-methoxy-benzaldehyde (162 mg) in 2 
mL of anhydrous DMF was treated with sodium methoxide in excess 
and refluxed at 125 °C for 3 h under nitrogen pressure. After cool-
ing, the obtained precipitate was purified by washing with toluene. 
C16H12N2O4S, 0.269 g (69%), mp 261-263 ºC; TLC silica gel plates 
type 60F254, Rf (C6H6:AcOEt 7:3) 0.72; IR (potassium bromide) νmax 
cm-1: 2956, 1665, 1604, 1512, 1343, 1255, 737. 1H NMR (300 MHz, 
DMSO-d6): d 3.83 (s, 3 H, OCH3), 7.09 (d, 2 H, H3’5’ phenyl) J 9 Hz, 
7.68 (d, 2 H, H2’6’ phenyl) J 8.7 Hz, 7.6 (d, 1 H, H8 benzothiazine) J 
8.7 Hz, 7.81 (s, 1 H, CH ethylene), 7.82 (dd, 1 H, H7 benzothiazine) J 
8.7 and 2.4 Hz, 7.89 (d, 1 H, H5 benzothiazine) J 2.4 Hz, 11.24 (s, 1 
H, NH); MS, m/z(%): 328(M+ 100), 313(3.94), 295(84.9), 296(50.7), 
281(14.1), 249(20).
(2Z)-2-(4-Methoxybenzylidene)-4-methyl-6-nitro-4H-
benzo[1,4]thiazin-3-one (8)
A solution of (2Z)-2-(4-methoxybenzylidene)-6-nitro-4H-
benzo[1,4]thiazin-3-one 7 (400 mg, 1.22 mmol) in DMSO/MEOH 
(5/6 mL) and potassium hydroxide (164 mg, 2.9 mmol) was stirred at 
room temperature for 10 min. Methyl iodide (0.18 mL, 2.43 mmol) 
was added dropwise under stirring. The mixture was stirred at 55 ºC 
for 15 h. After cooling, the crude was extracted with ethyl acetate. 
After the solvent evaporated, the compound was washed with ace-
tone. C17H14N2O4S, 0.267 g (64%), mp 147-150 °C; TLC silica gel 
plates type 60F254, (C6H6) 0.59, IR (potassium bromide) νmax cm-1: 
2925, 1649, 1601, 1511, 1342, 1254, 1021, 821; 1H NMR (300 MHz, 
DMSO-d6): d 3.56 (s, 3 H, CH3), 3.83 (s, 3 H, OCH3), 7.09 (d, 2 H, 
H3’5’ phenyl) J 8.7 Hz, 7.68 (d, 2 H, H2’6’ phenyl) J 9 Hz, 7.69 (d, 
1 H, H8 benzothiazine) J 8.1 Hz, 7.84 (s, 1 H, CH ethylene), 7.94 
(dd, 1 H, H7 benzothiazine) J 10.5 and 2.1 Hz, 7.96 (d, 1 H, H5 
benzothiazine) J 1.8 Hz; MS, m/z(%): 342(M+ 24,85), 314(5.75), 
310(58.9), 308(100), 306(30.7), 296(9.5), 292(14.6).
(2Z)-6-Amino-2-(4-methoxybenzylidene)-4H-benzo[1,4]thiazin-
3-one (9)
Over a period of 15 min, 100 mg (0.3 mmol) of compound (7) 
was added stepwise to a cold, stirring solution of 324 mg (0.3 mmol) 
of stannous dihydrate in 35 mL of concentrated HCl. The mixture was 
then left for 15 min at room temperature and refluxed for 2 h. After 
cooling, the precipitate was suspended in water and a 20% sodium 
hydroxide solution was added (pH 10) to produce the corresponding 
amine, which was collected and washed with 10% sodium hydroxide 
and water. C16H14N2O2S, 0.061 g (68%), mp 210-213 ºC; TLC silica 
gel plates type 60F254, Rf (CHCl3:EtOH 9:1) 0.58; IR (potassium 
bromide) ν
max 
cm-1: 3387, 3302, 3017, 2958, 2835, 1659, 1604, 1509, 
1253, 1173, 801. 1H NMR (300 MHz, DMSO-d6): d 3.81 (s, 3 H, 
OCH3), 5.24 (s, 2 H, NH2), 6.26 (d, 1 H, H5 benzothiazine) J 2.1 Hz, 
6.28 (d, 1 H, H7 benzothiazine) J 8.4 Hz, 6.90 (d, 1 H, H8 benzothia-
zine) J 8.1 Hz, 7.05 (d, 2 H, H3’5’ phenyl) J 9 Hz, 7.63 (d, 2 H, H2’6’ 
phenyl) J 9 Hz, 7.67 (s, 1 H, CH ethylene); MS, m/z(%): 299(MH+ 
14.34), 297(84.7), 265(100), 250(22.9), 237(13.1), 222(17.3).
(2Z)-6-Butylamino-2-(4-methoxybenzylidene)-4-methyl-4H-
benzo[1,4]thiazin-3-one (12) 
We successfully used the method of condensation described for 
(7). C21H24N2O2S, 0.055 g (50%), mp 102-104 ºC; TLC silica gel pla-
tes type 60F254, Rf (CHCl3:EtOH 9:1) 0.47; IR (KBr) νmax cm-1: 3371, 
2958, 2926, 1635, 1601, 1507, 1257, 1143, 827. 1H NMR (300 MHz, 
DMSO-d6): d 0.91 (t, 3 H, CH3 d) J 7.2 Hz, 1.31-1.44 (m, 2 H, CH2 b), 1.48-1.57 (m, 2 H, CH2 g), 2.98-3.04 (m, 2 H, CH2 a), 3.41 (s, 3 
H, NCH3), 3.81 (s, 3 H, OCH3), 5.79 (t, 1 H, NH) J 5.6 Hz, 6.33 (dd, 
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1 H, H7 benzothiazine) J 8.4 and 2.1 Hz, 6.43 (d, 1 H, H5 benzothia-
zine) J 2.1 Hz, 7.02 (d, 1 H, H8 benzothiazine) J 8.7 Hz, 7.05 (d, 2 
H, H3’5’ phenyl) J 9 Hz, 7.63 (d, 2 H, H2’6’ phenyl) J 9 Hz, 7.69 (s, 
1 H, CH ethylene); MS, m/z(%): 368(M+ 43.89), 367(100), 335(28), 
334(20.1), 326(13.3), 312(10.2), 309(11.6), 256(8.5).
SUPPLEMENTARY INFORMATION
Supplementary crystallographic data have been deposited in the 
Cambridge Crystallographic Data Center as supplementary publi-
cation No. CCDC 242133. Copies of the available material can be 
obtained, free of charge, by contacting the Director at CCDC, 12 
Union Road, Cambridge CH21EZ, UK (fax: +44-1223-336-033 or 
by e-mail: deposit@ccdc.cam.ac.uk or http://www.ccdc.cam.ac.uk.
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